May 14, 2026 08:35AM
May 14, 2026 08:35AM
Feb 4, 2026 08:47AM
Feb 4, 2026 08:45AM
May 15, 2025 08:35AM
May 15, 2025 08:35AM
Mar 17, 2025 08:05AM GRI Bio Reports Full Year 2024 Financial Results and Reiterates Expected Clinical Data Readouts in 2025 for Ongoing Phase 2a Study of GRI-0621 in Idiopathic Pulmonary Fibrosis (“IPF”)
Nov 14, 2024 04:20PM
Aug 14, 2024 08:05AM
May 13, 2024 08:00AM
Apr 1, 2024 07:35AM
Nov 15, 2023 08:05AM
Aug 14, 2023 08:05AM
May 22, 2023 08:45AM GRI Bio (NASDAQ: GRI) Provides Business Outlook and Highlights Upcoming Milestones for Innovative Pipeline of NKT Cell Modulators
Apr 25, 2023 08:45AM
Apr 25, 2023 08:45AM
Apr 24, 2023 08:05AM
Jul 8, 2016 09:23AM
Sep 21, 2015 08:00AM
Mar 23, 2015 09:00AM

1,197,452 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All